BioengineeringbioRxivPreprint
RELB Reprograms Exhausted Tumor-Infiltrating Lymphocytes for Improved Adoptive Cell Therapy
Christian D. McRoberts Amador, Rachel E. Conover, Michael C. Brown…·Charles A. Gersbach
This study identifies RELB as a key regulator that enhances TIL expansion and function, improving adoptive cell therapy for solid tumors.